Jemincare spares efforts to become an international and modernization pharmaceutical industry and uses global vision to develop businesses, arranges netword and integrates resources.
In various fields like academic research, drug research and development, drug production, we have finished the construction of global nodes. Except the Chinese Mainland, Hong Kong, Macao and Taiwan,we have set up institutions. We cooperates extensively with the world’s leading medical institutions in accelerating new drug research; We also introduce advanced pharmaceutical technology and experience from Germany, Italy and other cuontries through many ways such as resources integration to improve the quality of drugs. In May 2018, the global scientific headquarters settled in Shanghai, and the Jemincare group moved towards the starting point of globalization. Jemincare cooperates extensively with the world's leading medical sciences in accelerating new drug research. Using the advanced pharmaceutical technologies to turn the frontier achievements into high-quality medicines The future, Jemincare group will expand the international influence of the enterprise and the national "one belt and one way" strategy, build and improve the business network, and uses the global wisdom to serve human health.
Group business partners
Global business In recent years, the Group has strengthened academic promotion, advocated precisive service tapped customer value, spared efforts to improve the brand influence and cooperated with foreign countries to develop overseas markets.